glp 1 agonists drugs How GLP-1 Receptor Evolved from Diabetes to Weight Loss Treatments Market Overview: GLP-1 Agonists and

A major new study reveals that women who discontinued these medications gained over 3 kg more during pregnancy compared to those who never used them

A recent study, published in the Journal of Pharmacy and Pharmacology Research, sugges

This article examines clinical evidence for combination therapy, safety profiles, and how genetic predispositions in GLP-1 and glucose metabolism pathways may info

Objective This systematic review aims to synthesise published evidence on respiratory adverse events temporally associated with GLP-1 RA therapy in adults, characterise their patterns and severity, appraise the risk of bias using validated design-appropriate tools, describe proposed pathophysiological mechanisms, and grade the certainty of evidence using the Grading of Recommendations Assessment, Development, and Evaluation (GRADE) framework

Glucagon-like peptide-1 (GLP-1) is an incretin peptide hormone mainly secreted by enteroendocrine intestinal L-cells

Interestingly, this raises important points in regard to the need to hold GLP-1 RAs prior to concurrent EGD and colonoscopy procedures and the number of days needed to hold these agents, if necessary